专家文章 | 莫曾南

搜索
登录

热心肠智库专家文章 | 莫曾南

2024

CASingle-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer

J Transl Med, 10.1186/s12967-024-04860-1

2023

CAThe optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer

BMC CANCER, 10.1186/s12885-023-11523-9

CAA gene signature of cancer-associated fibroblasts predicts prognosis and treatment response in bladder cancer

CLIN TRANSL ONCOL, 10.1007/s12094-023-03270-x

CAA new insight of immunosuppressive microenvironment in osteosarcoma lung metastasis

EXP BIOL MED, 10.1177/15353702231171900

CAUpregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma

CLIN TRANSL ONCOL, 10.1007/s12094-023-03228-z

CAScreening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data

Biomolecules, 10.3390/biom13040685

CAEstablishment of a risk score model for bladder urothelial carcinoma based on energy metabolism-related genes and their relationships with immune infiltration

FEBS openbio, 10.1002/2211-5463.13580

CAAssociations of circulation levels of cytokines with birthweight, preterm birth, spontaneous miscarriages, and stillbirth: A Mendelian randomization analysis

Front Genet, 10.3389/fgene.2023.1113804

CAIdentification of Five Tumor Antigens for Development and Two Immune Subtypes for Personalized Medicine of mRNA Vaccines in Papillary Renal Cell Carcinoma

Journal of Personalized Medicine, 10.3390/jpm13020359

CAThe role of CRYAB in tumor prognosis and immune infiltration: A Pan-cancer analysis

Frontiers in Surgery, 10.3389/fsurg.2022.1117307

CAThe role of CRYAB in tumor prognosis and immune infiltration: A Pan-cancer analysis

Frontiers in Surgery, 10.3389/fsurg.2022.1117307

CAIntegrative single-cell analysis reveals transcriptional and epigenetic regulatory features of clear cell renal cell carcinoma

Cancer Res, 10.1158/0008-5472.CAN-22-2224

2022

CAUrinary exosomal prostate-specific antigen is a noninvasive biomarker to detect prostate cancer: Not only old wine in new bottles

INT J CANCER, 10.1002/ijc.34388

CALong noncoding RNA as a potential diagnostic tool for prostate cancer: a systematic review and meta-analysis

BIOMARKERS, 10.1080/1354750X.2022.2142293

CAA spatiotemporal steroidogenic regulatory network in human fetal adrenal glands and gonads

FRONT ENDOCRINOL, 10.3389/fendo.2022.1036517

CADissection of tumor antigens and immune landscape in clear cell renal cell carcinoma: Preconditions for development and precision medicine of mRNA vaccine

MBE, 10.3934/mbe.2023100

CAIdentification of Immune-Related Subtypes and Construction of a Novel Prognostic Model for Bladder Urothelial Cancer

Biomolecules, 10.3390/biom12111670

CATLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer

Front Genet, 10.3389/fgene.2022.905988

CAUrine-derived exosomal PSMA is a promising diagnostic biomarker for the detection of prostate cancer on initial biopsy

CLIN TRANSL ONCOL, 10.1007/s12094-022-02983-9

CAThe epiphany derived from T-cell-inflamed profiles: Pan-cancer characterization of CD8A as a biomarker spanning clinical relevance, cancer prognosis, immunosuppressive environment, and treatment responses

Front Genet, 10.3389/fgene.2022.974416